GlassScriptPhysician profile
Nolan Schmitz
NPI 1083291975
$4,195.33
in general payments reported to CMS, 2019-2025
14 companies · $3,061 in 2025
The $3,061 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $257 · 2024: $878 · 2025: $3,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195 · Grant: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.33 |
| Grant | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,010.87 | 2025 | |
| Si-Bone, INC. | $489.03 | 2024-2025 | |
| Stryker Corporation | $293.71 | 2023-2025 | Accolade, Triathlon, Mako |
| Polynovo North America LLC | $212.57 | 2024 | Novosorb Btm |
| Depuy Synthes Sales INC. | $210.31 | 2024-2025 | Na, Fibergraft Bg Morsels, Motoband Cp |
| Acera Surgical, INC. | $156.57 | 2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $139.88 | 2025 | Irrisept |
| Orthofix Medical, INC. | $136.57 | 2024 | Spinal-Stim |
| Abbott Laboratories | $127.28 | 2024 | Eterna |
| Heron Therapeutics, INC. | $121.74 | 2023 | Zynrelef |
| Boston Scientific Corporation | $111.77 | 2024 | General Pain Management Nmd |
| Cosa Medical, LLC | $96.13 | 2025 | |
| Medtronic, INC. | $71.90 | 2025 | Unid_pass |
| Vericel Corporation | $17.00 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nolan Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.